Ponatinib
Tyrosine Kinase Inhibitors
Product Specifications
Background
Ponatinib is a multi-targeted tyrosine kinase inhibitor. This agent also inhibits other tyrosine kinases including those associated with vascular endothelial growth factor receptors (VEGFRs) and fibroblast growth factor receptors (FGFRs).
CAS Number
943319-70-8
Product Name Alternative
3- (2-Imidazo[1,2-b]pyridazin-3-ylethynyl) -4-methyl-N-[4-[ (4-methyl-1-piperazinyl) methyl]-3- (trifluoromethyl) phenyl]-benzamide, AP-24534
UNSPSC
41116105
Type
Inhibitor
Source
Synthetic
Field of Research
Cancer | Cancer Growth Inhibitors | Tyrosine Kinase Inhibitors
Purity
>98% (HPLC) ; NMR (Conforms)
Weight
0.005
Format
Yellow powder
Solubility
May be dissolved in DMSO (50 mg/ml); or Ethanol (25 mg/ml, warm)
Molecular Formula
C29H27F3N6O
Molecular Weight
532.6
Precautions
Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC401574-100 1x 100 µL
HIF1 alpha (Hypoxia-Inducible Factor 1-alpha) (ESEE122), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
